Igm Biosciences Stock Return On Asset
| IGMS Stock | USD 1.27 0.06 4.96% |
IGM Biosciences fundamentals help investors to digest information that contributes to IGM Biosciences' financial success or failures. It also enables traders to predict the movement of IGM Stock. The fundamental analysis module provides a way to measure IGM Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to IGM Biosciences stock.
IGM |
IGM Biosciences Company Return On Asset Analysis
IGM Biosciences' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current IGM Biosciences Return On Asset | -0.35 |
Most of IGM Biosciences' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IGM Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, IGM Biosciences has a Return On Asset of -0.3523. This is 95.97% lower than that of the Biotechnology sector and 98.51% lower than that of the Health Care industry. The return on asset for all United States stocks is 151.64% higher than that of the company.
IGM Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IGM Biosciences' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IGM Biosciences could also be used in its relative valuation, which is a method of valuing IGM Biosciences by comparing valuation metrics of similar companies.IGM Biosciences is currently under evaluation in return on asset category among its peers.
IGM Fundamentals
| Return On Equity | -1.56 | ||||
| Return On Asset | -0.35 | ||||
| Operating Margin | (59.75) % | ||||
| Current Valuation | (62.69 M) | ||||
| Shares Outstanding | 34.39 M | ||||
| Shares Owned By Insiders | 38.81 % | ||||
| Shares Owned By Institutions | 59.41 % | ||||
| Number Of Shares Shorted | 1.07 M | ||||
| Price To Earning | (7.72) X | ||||
| Price To Book | 1.58 X | ||||
| Price To Sales | 28.34 X | ||||
| Revenue | 2.68 M | ||||
| Gross Profit | (152.51 M) | ||||
| EBITDA | (208.58 M) | ||||
| Net Income | (195.79 M) | ||||
| Cash And Equivalents | 469.14 M | ||||
| Cash Per Share | 10.95 X | ||||
| Total Debt | 45.19 M | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 10.79 X | ||||
| Book Value Per Share | 0.81 X | ||||
| Cash Flow From Operations | (153 M) | ||||
| Short Ratio | 4.14 X | ||||
| Earnings Per Share | (3.24) X | ||||
| Target Price | 3.03 | ||||
| Number Of Employees | 149 | ||||
| Beta | 0.36 | ||||
| Market Capitalization | 75.91 M | ||||
| Total Asset | 265.71 M | ||||
| Retained Earnings | (1.02 B) | ||||
| Working Capital | 155.98 M | ||||
| Current Asset | 1.23 M | ||||
| Current Liabilities | 3.37 M | ||||
| Net Asset | 265.71 M |
About IGM Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze IGM Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IGM Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IGM Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for IGM Stock Analysis
When running IGM Biosciences' price analysis, check to measure IGM Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGM Biosciences is operating at the current time. Most of IGM Biosciences' value examination focuses on studying past and present price action to predict the probability of IGM Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IGM Biosciences' price. Additionally, you may evaluate how the addition of IGM Biosciences to your portfolios can decrease your overall portfolio volatility.